310 related articles for article (PubMed ID: 31186027)
1. Long-term functional outcome after laryngeal cancer treatment.
Anschuetz L; Shelan M; Dematté M; Schubert AD; Giger R; Elicin O
Radiat Oncol; 2019 Jun; 14(1):101. PubMed ID: 31186027
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases.
Bussu F; Miccichè F; Rigante M; Dinapoli N; Parrilla C; Bonomo P; Cadoni G; Mantini G; Galli J; Rufini V; Almadori G; Valentini V; Paludetti G
Head Neck; 2012 Apr; 34(4):573-9. PubMed ID: 21692130
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
5. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
6. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
7. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
[TBL] [Abstract][Full Text] [Related]
8. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
[TBL] [Abstract][Full Text] [Related]
9. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term outcomes of laryngeal cancer care in the elderly.
Gourin CG; Starmer HM; Herbert RJ; Frick KD; Forastiere AA; Eisele DW; Quon H
Laryngoscope; 2015 Apr; 125(4):924-33. PubMed ID: 25367258
[TBL] [Abstract][Full Text] [Related]
11. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
12. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
14. Salvage surgery for recurrent larynx cancer.
Mimica X; Hanson M; Patel SG; McGill M; McBride S; Lee N; Dunn LA; Cracchiolo JR; Shah JP; Wong RJ; Ganly I; Cohen MA
Head Neck; 2019 Nov; 41(11):3906-3915. PubMed ID: 31433540
[TBL] [Abstract][Full Text] [Related]
15. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
16. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome following total laryngectomy for cancer.
Hall FT; O'Brien CJ; Clifford AR; McNeil EB; Bron L; Jackson MA
ANZ J Surg; 2003 May; 73(5):300-5. PubMed ID: 12752286
[TBL] [Abstract][Full Text] [Related]
19. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases.
Weiss BG; Bertlich M; Canis M; Ihler F
Head Neck; 2017 Jun; 39(6):1166-1176. PubMed ID: 28252821
[TBL] [Abstract][Full Text] [Related]
20. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]